Galenica makes 1.0% of wage bill available for salary increases

This decision comes despite the fact that continuing drug price reductions, growing competition in the retail market, ongoing consumer tourism and a generally stagnant Swiss retail market will continue to be challenges for the entire healthcare value chain in 2018.

Individual salary increases at the Galenica Group are performance-related or are made in connection with a change in function. The salary increases will be applied from January 2018.